Hims & Hers Health (HIMS): Chief Commercial Officer sold ~$458K
Michael Chi, Chief Commercial Officer at Hims & Hers Health, sold ~$458K of Hims & Hers Health shares.
- ~$458K
- Approx. value · 17K sh @ $26.49
- 185K
- Holds after · shares reported
- Traded
- Nov 25, 2024
- Filed
- Nov 26, 2024
What stands out in this filing
- The sale was 8.6% of the shares this insider held before it; the filing reports 184,947 shares afterwards.
- 17,303 shares at an average of $26.49 each, as reported on the form.
- Footnote references a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 1, 2024Insider · 2 peopleInsiders: 4 sales (~$6.1M)
- Oct 2, 2024Insider · 1 personInsiders: 3 sales (~$219K)
- Oct 7, 2024Insider · 2 peopleInsiders: 3 sales (~$1.3M)
- Oct 14, 2024Insider · 1 personInsiders: 7 sales (~$5.5M)
- Oct 15, 2024Insider · 2 peopleInsiders: 2 sales (~$1.7M)
- Oct 16, 2024InsiderOfficer sold ~$11K of HIMS shares in the open market
- Oct 21, 2024InsiderOfficer sold ~$167K of HIMS shares in the open market
- Oct 25, 2024InsiderOfficer sold ~$381K of HIMS shares in the open market
- Oct 29, 2024InsiderOfficer sold ~$54K of HIMS shares in the open market
- Nov 5, 2024Insider · 2 peopleInsiders: 7 sales (~$7.0M)
- Nov 6, 2024InsiderDirector sold ~$331K of HIMS shares in the open market
- Nov 11, 2024Insider · 2 peopleInsiders: 2 sales (~$313K)
- Nov 12, 2024Insider · 2 peopleInsiders: 1 purchase (~$108K), 1 sale (~$62K)
- Nov 13, 2024Insider · 2 peopleInsiders: 5 sales (~$5.5M)
- Nov 14, 2024InsiderDirector purchased ~$25K of HIMS shares in the open market
- Nov 18, 2024Insider · 2 peopleInsiders: 5 sales (~$1.2M)
- Nov 19, 2024InsiderOfficer sold ~$165K of HIMS shares in the open market
- Nov 25, 2024 · this disclosureInsiderOfficer sold ~$458K of HIMS shares in the open market
What came next
- Nov 25, 2024Insider · 1 personInsiders: 4 sales (~$3.0M)
- Nov 26, 2024InsiderOfficer sold ~$70K of HIMS shares in the open market
- Dec 2, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
- Dec 10, 2024Insider · 2 peopleInsiders: 4 sales (~$2.9M)
- Dec 16, 2024Insider · 2 peopleInsiders: 7 sales (~$3.7M)
- Dec 17, 2024Insider · 3 peopleInsiders: 4 sales (~$3.7M)
- Dec 19, 2024InsiderOfficer sold ~$195K of HIMS shares in the open market
- Dec 20, 2024Insider · 1 personInsiders: 4 sales (~$489K)
- Dec 24, 2024InsiderOfficer sold ~$484K of HIMS shares in the open market
- Dec 26, 2024InsiderCFO sold ~$126K of HIMS shares in the open market
- Jan 2, 2025Insider · 2 peopleInsiders: 3 sales (~$312K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Hims & Hers Health
For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.
Other recent filings by Michael Chi, Chief Commercial Officer
- SEC Form 4 at Hims & Hers Health (HIMS)Sep 17, 2026
- SEC Form 4 at Hims & Hers Health (HIMS)Jun 17, 2026
- SEC Form 4 at Hims & Hers Health (HIMS)Mar 18, 2026
- SEC Form 4 at Hims & Hers Health (HIMS)Dec 18, 2025
- SEC Form 4 at Hims & Hers Health (HIMS)Oct 14, 2025
The full history of Michael Chi, Chief Commercial Officer is on the profile page.
How this filing works
Explore the data
Common questions
Which Hims & Hers Health (HIMS) insider traded, and how much?
Michael Chi, Chief Commercial Officer at Hims & Hers Health, sold ~$458K of Hims & Hers Health shares. 17K shares at $26.49.
When did it happen, and when was it made public?
Traded: Nov 25, 2024. Filed: Nov 26, 2024. That is 1 day between the two dates.
What stands out in this filing?
The sale was 8.6% of the shares this insider held before it; the filing reports 184,947 shares afterwards. 17,303 shares at an average of $26.49 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Hims & Hers Health recently?
For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.
Does this mean HIMS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Hims & Hers Health
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 144Nov 17, 2026
- SEC Form 144Nov 17, 2026
Everything OQRO holds on this company is on its HIMS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
